Drug Trials Snapshots: REYVOW

10:08 EST 7 Nov 2019 | FDA

REYVOW is a drug used for the acute treatment of migraine with or without aura in adults. A migraine is a type of headache that, is associated with pain nausea, vomiting, and sensitivity to light or sound. Patients develop temporary visual or other signs and symptoms prior to headache onset.

Original Article: Drug Trials Snapshots: REYVOW


More From BioPortfolio on "Drug Trials Snapshots: REYVOW"

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...